| Line Item | Jun 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EXPENSES | |||||||||||||
| Research and Development Expense | |||||||||||||
| Depreciation Expense | |||||||||||||
| Selling, General and Administrative Expense | |||||||||||||
| Investor relations and communications | |||||||||||||
| Total Operating Expenses | |||||||||||||
| Fair value movement of DSUs | |||||||||||||
| Net foreign exchange (gain) loss | — | — | |||||||||||
| LOSS FOR THE PERIOD BEFORE OTHER ITEMS | |||||||||||||
| OTHER ITEMS | |||||||||||||
| Interest income, net | |||||||||||||
| Interest expense and accretion on Term Loan | — | ||||||||||||
| Loss on Term Loan extinguishment | — | ||||||||||||
| NET LOSS FOR THE PERIOD | |||||||||||||
| Earnings Per Share (Basic) | |||||||||||||
| Earnings Per Share (Diluted) |